Search Results - Flospergher, E

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    THE IELSG39 TRIAL: EFFICACY OF FIRST‐LINE CHLAMYDIA PSITTACI ERADICATION WITH A SIX‐MONTH REGIMEN OF DOXYCYCLINE IN PATIENTS WITH STAGE‐I MALT LYMPHOMA OF THE OCULAR ADNEXAE

    THE IELSG39 TRIAL: EFFICACY OF FIRST‐LINE CHLAMYDIA PSITTACI ERADICATION WITH A SIX‐MONTH REGIMEN OF DOXYCYCLINE IN PATIENTS WITH STAGE‐I MALT LYMPHOMA OF THE OCULAR ADNEXAE by Ferreri, A. J. M., Sassone, M. C., Cangi, M. G., Magliacane, G., Zanussi, S., Marino, F., Flospergher, E., Vicari, N., Bongiovanni, L., Cin, E. Dal, Cavallo, F., Re, F., Anastasia, A., Mannina, D., Bassan, R., Vallisa, D, Pulsoni, A., Bonomini, L., Bertoni, F., Dolcetti, R., Zucca, E., Ponzoni, M.

    Published in Hematological oncology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

    17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023 by Ferreri, A J M, Sassone, M C, Cangi, M G, Magliacane, G, Zanussi, S, Marino, F, Flospergher, E, Vicari, N, Bongiovanni, L, Cin, E Dal, Cavallo, F, Re, F, Anastasia, A, Mannina, D, Bassan, R, Vallisa, D, Pulsoni, A, Bonomini, L, Bertoni, F, Dolcetti, R, Zucca, E, Ponzoni, M

    Published in Hematological oncology
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    SAFETY AND EFFICACY OF THE “CARMEN” REGIMEN, A NEW DOSE‐DENSE SHORT‐TERM THERAPY IN PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA AND MYC REARRANGEMENT

    SAFETY AND EFFICACY OF THE “CARMEN” REGIMEN, A NEW DOSE‐DENSE SHORT‐TERM THERAPY IN PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA AND MYC REARRANGEMENT by Ferreri, A. J. M, Angelillo, P, Erbella, F, Liberatore, C, Cattaneo, C, Verga, L, Lleshi, A, Allione, B, Facchetti, F, Ponzoni, M, Pagani, C, Foppoli, M, Pecciarini, L, Sassone, M. C, Flospergher, E, Rossi, G, Spina, M, A. Re

    Published in Hematological oncology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    A risk‐stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders

    A risk‐stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopa... by Varettoni, Marzia, Zibellini, Silvia, Boveri, Emanuela, Klersy, Catherine, Candido, Chiara, Rattotti, Sara, Ferretti, Virginia V., Defrancesco, Irene, Mangiacavalli, Silvia, Nizzoli, Maria E., Flospergher, Elena, Zerbi, Caterina, Bergamini, Fabio, Benvenuti, Pietro, Brociner, Marco, Merati, Gabriele, Paulli, Marco, Arcaini, Luca

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    A risk‐stratification model based on the initial concentration of the serum monoclonal protein and MYD 88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders

    A risk‐stratification model based on the initial concentration of the serum monoclonal protein and MYD 88 mutation status identifies a subset of patients with IgM monoclonal gammop... by Varettoni, Marzia, Zibellini, Silvia, Boveri, Emanuela, Klersy, Catherine, Candido, Chiara, Rattotti, Sara, Ferretti, Virginia V., Defrancesco, Irene, Mangiacavalli, Silvia, Nizzoli, Maria E., Flospergher, Elena, Zerbi, Caterina, Bergamini, Fabio, Benvenuti, Pietro, Brociner, Marco, Merati, Gabriele, Paulli, Marco, Arcaini, Luca

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: